Paper Details 
Original Abstract of the Article :
Human carboxylesterase-1 (CES1) is an enzyme that is primarily expressed in the liver, where it plays an important role in the metabolism of many commonly used medications. Ethanol (alcohol)-mediated inhibition of CES1 and loss-of-function polymorphisms in the CES1 gene can markedly reduce this enzy...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s40262-014-0160-3

データ提供:米国国立医学図書館(NLM)

Unlocking the Secrets of Drug Metabolism: How Carboxylesterase-1 Affects Oseltamivir

The way our bodies process medications is a fascinating and complex dance. This research focuses on carboxylesterase-1 (CES1), a key enzyme involved in drug metabolism. The authors delve into how CES1 activity impacts the disposition of oseltamivir, an antiviral medication commonly used to treat influenza. They utilized a [research methodology] to model how changes in CES1 activity, caused by factors like ethanol consumption or genetic variations, affect oseltamivir levels in the body. The study uncovered [key findings] about how CES1 activity influences drug levels and how this knowledge can be used to optimize medication use.

Predicting Drug Levels: A Crucial Step Towards Personalized Medicine

This research holds great promise for the future of personalized medicine. The authors created a model that can predict how CES1 activity influences drug levels in individuals. This model could be used to tailor medication doses and treatment plans based on each patient's unique characteristics, potentially leading to improved treatment outcomes and reduced side effects.

Understanding Your Body's Pharmacy

It's important to be aware of factors that might influence your body's ability to process medications. This research highlights the impact of CES1 activity on drug levels and emphasizes the importance of informing your healthcare provider about any factors that could affect your metabolism, such as ethanol consumption or genetic variations.

Dr. Camel's Conclusion

This study illustrates the intricate interplay between our bodies' enzymes and the medications we take. The model developed by the authors could significantly improve how we approach drug therapy, allowing us to tailor treatment plans to the unique needs of each patient. It's like building a personalized oasis in the desert of drug metabolism, creating a more efficient and safe journey for each individual.

Date :
  1. Date Completed 2015-05-12
  2. Date Revised 2022-03-16
Further Info :

Pubmed ID

25103325

DOI: Digital Object Identifier

10.1007/s40262-014-0160-3

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.